11-90163289-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000532691.1(NAALAD2):​n.798C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.54 in 1,596,804 control chromosomes in the GnomAD database, including 238,578 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.62 ( 31372 hom., cov: 32)
Exomes 𝑓: 0.53 ( 207206 hom. )

Consequence

NAALAD2
ENST00000532691.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0810

Publications

12 publications found
Variant links:
Genes affected
NAALAD2 (HGNC:14526): (N-acetylated alpha-linked acidic dipeptidase 2) This gene is a member of the N-acetylated alpha-linked acidic dipeptidase (NAALADase) gene family. The representative member of this family is the gene encoding human prostate-specific membrane antigen (PSM), which is a marker of prostatic carcinomas and is the first to be shown to possess NAALADase activity. NAALADase cleaves N-acetyl-L-aspartate-L-glutamate (NAAG), which is a neuropeptide expressed both in the central nervous systems and in the periphery and is thought to function as a neurotransmitter. The product of this gene is a type II integral membrane protein. Transient transfection of this gene confers both NAALADase and dipetidyl peptidase IV activities to mammalian cells. This gene is highly expressed in ovary and testis as well as within discrete brain areas. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.847 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NAALAD2NM_005467.4 linkc.1076-21C>T intron_variant Intron 9 of 18 ENST00000534061.6 NP_005458.1 Q9Y3Q0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NAALAD2ENST00000534061.6 linkc.1076-21C>T intron_variant Intron 9 of 18 1 NM_005467.4 ENSP00000432481.1 Q9Y3Q0-1

Frequencies

GnomAD3 genomes
AF:
0.624
AC:
94734
AN:
151840
Hom.:
31323
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.854
Gnomad AMI
AF:
0.453
Gnomad AMR
AF:
0.645
Gnomad ASJ
AF:
0.524
Gnomad EAS
AF:
0.469
Gnomad SAS
AF:
0.615
Gnomad FIN
AF:
0.544
Gnomad MID
AF:
0.563
Gnomad NFE
AF:
0.512
Gnomad OTH
AF:
0.602
GnomAD2 exomes
AF:
0.571
AC:
136994
AN:
240094
AF XY:
0.563
show subpopulations
Gnomad AFR exome
AF:
0.863
Gnomad AMR exome
AF:
0.690
Gnomad ASJ exome
AF:
0.518
Gnomad EAS exome
AF:
0.460
Gnomad FIN exome
AF:
0.541
Gnomad NFE exome
AF:
0.515
Gnomad OTH exome
AF:
0.544
GnomAD4 exome
AF:
0.531
AC:
767515
AN:
1444846
Hom.:
207206
Cov.:
33
AF XY:
0.532
AC XY:
382524
AN XY:
718770
show subpopulations
African (AFR)
AF:
0.864
AC:
27984
AN:
32372
American (AMR)
AF:
0.687
AC:
28170
AN:
41012
Ashkenazi Jewish (ASJ)
AF:
0.525
AC:
13302
AN:
25354
East Asian (EAS)
AF:
0.479
AC:
18976
AN:
39634
South Asian (SAS)
AF:
0.613
AC:
51188
AN:
83528
European-Finnish (FIN)
AF:
0.538
AC:
28603
AN:
53184
Middle Eastern (MID)
AF:
0.556
AC:
3147
AN:
5660
European-Non Finnish (NFE)
AF:
0.511
AC:
563968
AN:
1104450
Other (OTH)
AF:
0.539
AC:
32177
AN:
59652
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
16428
32856
49283
65711
82139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16484
32968
49452
65936
82420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.624
AC:
94851
AN:
151958
Hom.:
31372
Cov.:
32
AF XY:
0.625
AC XY:
46412
AN XY:
74238
show subpopulations
African (AFR)
AF:
0.854
AC:
35449
AN:
41490
American (AMR)
AF:
0.646
AC:
9857
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.524
AC:
1819
AN:
3470
East Asian (EAS)
AF:
0.469
AC:
2416
AN:
5148
South Asian (SAS)
AF:
0.615
AC:
2960
AN:
4814
European-Finnish (FIN)
AF:
0.544
AC:
5737
AN:
10542
Middle Eastern (MID)
AF:
0.575
AC:
169
AN:
294
European-Non Finnish (NFE)
AF:
0.512
AC:
34756
AN:
67910
Other (OTH)
AF:
0.605
AC:
1276
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1656
3311
4967
6622
8278
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
750
1500
2250
3000
3750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.555
Hom.:
33397
Bravo
AF:
0.643
Asia WGS
AF:
0.594
AC:
2064
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.3
DANN
Benign
0.68
PhyloP100
-0.081
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs489009; hg19: chr11-89896457; COSMIC: COSV58959658; COSMIC: COSV58959658; API